These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. On cross-priming of MHC class I-specific CTL: rule or exception? Zinkernagel RM Eur J Immunol; 2002 Sep; 32(9):2385-92. PubMed ID: 12207322 [No Abstract] [Full Text] [Related]
5. Immunology. Accessory to murder. Schumacher TN Nature; 1999 Mar; 398(6722):26-7. PubMed ID: 10078525 [No Abstract] [Full Text] [Related]
6. Class I antigen presentation. Jelachich ML; Biddison WE Year Immunol; 1989; 4():41-58. PubMed ID: 2522701 [No Abstract] [Full Text] [Related]
7. Viral evasion of antigen presentation: not just for peptides anymore. Van Kaer L; Joyce S Nat Immunol; 2006 Aug; 7(8):795-7. PubMed ID: 16855602 [No Abstract] [Full Text] [Related]
8. Cross priming or direct priming: is that really the question? Norbury CC; Sigal LJ Curr Opin Immunol; 2003 Feb; 15(1):82-8. PubMed ID: 12495738 [No Abstract] [Full Text] [Related]
9. Making sense of mass destruction: quantitating MHC class I antigen presentation. Yewdell JW; Reits E; Neefjes J Nat Rev Immunol; 2003 Dec; 3(12):952-61. PubMed ID: 14647477 [No Abstract] [Full Text] [Related]
10. Subversion of the MHC class I antigen-presentation pathway by adenoviruses and herpes simplex viruses. Burgert HG Trends Microbiol; 1996 Mar; 4(3):107-12. PubMed ID: 8868089 [No Abstract] [Full Text] [Related]
11. Cross-presentation: underlying mechanisms and role in immune surveillance. Rock KL; Shen L Immunol Rev; 2005 Oct; 207():166-83. PubMed ID: 16181335 [TBL] [Abstract][Full Text] [Related]